Task: Answer the multiple choice question.
Question: Which drug exhibits a 17.084% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) O=C(c1ccc2c(c1)C(=O)N(Cc1ccco1)C2O)N1CCOCC1
b.) N#Cc1c(-c2ccccc2)[nH]c(=S)[nH]c1=O
Answer: b. N#Cc1c(-c2ccccc2)[nH]c(=S)[nH]c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#Cc1c(-c2ccccc2)[nH]c(=S)[nH]c1=O
N#Cc1c(-c2ccccc2)[nH]c(=S)[nH]c1=O
4-oxo-6-phenyl-2-sulfanylidene-1H-pyrimidine-5-carbonitrile